Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Vojtesek

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Cell Cycle (Georgetown, Tex.)|March 20, 2015
TAp63gamma is required for the late stages of myogenesisS Cefalù, A M Lena, B Vojtesek, et al.
The Biochemical Journal|August 5, 1999
Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancersA L Craig, L Burch, B Vojtesek, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|April 13, 2013
A combined immunoprecipitation and mass spectrometric approach to determine deltaNp63-interacting partnersL Hernychova, M Nekulova, D Potesil, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 23, 2008
[Chemosensitivity prediction in tumor cells ex vivo--difficulties and limitations of the method]E Michalová, A Poprach, I Nemecková, et al.
Gut|August 1, 1997
Biochemical analysis of the stress protein response in human oesophageal epitheliumD Hopwood, S Moitra, B Vojtesek, et al.
The International Journal of Biological Markers|April 15, 2008
Identification of alphaB-crystallin, a biomarker of renal cell carcinoma by SELDI-TOF MSJ Holcakova, L Hernychova, P Bouchal, et al.
The Journal of Biological Chemistry|November 18, 2000
Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcriptionJ P Blaydes, M G Luciani, S Pospisilova, et al.
British Journal of Cancer|June 1, 1995
Absence of p53 autoantibodies in a significant proportion of breast cancer patientsB Vojtesek, J Kovarik, H Dolezalova, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|January 30, 1995
On the regulation of the p53 tumour suppressor, and its role in the cellular response to DNA damageD P Lane, C A Midgley, T R Hupp, et al.
Oncogene|July 25, 2012
C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balancesP Muller, E Ruckova, P Halada, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|March 20, 2015
TAp63gamma is required for the late stages of myogenesisS Cefalù, A M Lena, B Vojtesek, et al.
The Biochemical Journal|August 5, 1999
Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancersA L Craig, L Burch, B Vojtesek, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|April 13, 2013
A combined immunoprecipitation and mass spectrometric approach to determine deltaNp63-interacting partnersL Hernychova, M Nekulova, D Potesil, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 23, 2008
[Chemosensitivity prediction in tumor cells ex vivo--difficulties and limitations of the method]E Michalová, A Poprach, I Nemecková, et al.
Gut|August 1, 1997
Biochemical analysis of the stress protein response in human oesophageal epitheliumD Hopwood, S Moitra, B Vojtesek, et al.
The International Journal of Biological Markers|April 15, 2008
Identification of alphaB-crystallin, a biomarker of renal cell carcinoma by SELDI-TOF MSJ Holcakova, L Hernychova, P Bouchal, et al.
The Journal of Biological Chemistry|November 18, 2000
Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcriptionJ P Blaydes, M G Luciani, S Pospisilova, et al.
British Journal of Cancer|June 1, 1995
Absence of p53 autoantibodies in a significant proportion of breast cancer patientsB Vojtesek, J Kovarik, H Dolezalova, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|January 30, 1995
On the regulation of the p53 tumour suppressor, and its role in the cellular response to DNA damageD P Lane, C A Midgley, T R Hupp, et al.
Oncogene|July 25, 2012
C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balancesP Muller, E Ruckova, P Halada, et al.
Pageof 5